Latest Distributions News

Magellan Asset Management has announced target cash distributions for its suite of funds for the six-month period ending June 30, 2025, signaling steady income expectations for investors.

Spheria Emerging Companies Limited has announced a fully franked ordinary dividend of AUD 0.035 per share for the quarter ending December 2024, with a Dividend Reinvestment Plan available to shareholders.

Spheria Emerging Companies Limited has declared a fully franked quarterly dividend of 3.5 cents per share, reflecting its commitment to increased shareholder returns following a robust portfolio performance in Q4 2024.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 stores nationwide, marking a pivotal step in its Australian market expansion.

Mirrabooka Investments Limited has announced a fully franked dividend of AUD 0.045 per share for the half-year ending December 2024, payable in February 2025. The company continues to offer shareholders participation options through its Dividend Reinvestment Plan and Bonus Security Plan.

Northern Minerals has reported a 15% increase in the total rare earth oxides (TREO) at its Wolverine deposit, with a striking 75% rise in Measured and Indicated TREO tonnes, underpinning the next phase of its Browns Range project development.

Pro Medicus has secured a $33 million, nine-year contract to implement its Visage 7 cloud-based imaging platform across the University of Kentucky’s health system, marking a significant expansion in North American academic healthcare.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 NRI stores nationwide. This partnership aims to boost RLF’s Australian market presence and support sustainable farming practices.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Latitude Group Holdings Limited has revised its distribution on Capital Notes from AUD 1.6136 to AUD 2.3052, reflecting a shift to a 0% franked component and the introduction of conduit foreign income.

Advance ZincTek reports steady profit before tax for H1 FY25, driven by strong North American growth and significant cost savings following its Perth facility closure.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.